Florida Biologix competitors

Key experiences in leading mergers and acquisitions, working with financial institutions and markets, driving exceptional growth in revenue and profit, developing organizations, managing organizational performance, and planning strategic growth. Specialties: Mergers and acquisitions, General Management, Marketing, Sales, Quality Systems.

Wang Yan are a Chief Executive Officer at Cytovance Biologics, President at Scientific Protein Labs Llc, and Board Member at Cytovance Biologics. They have worked as VP:Business Development at Scientific Protein Labs Llc.

Highly motivated senior executive with general management experience in both large multi-national companies and small private equity environments in the diagnostic, medical device, pharmaceutical and life science industries. Demonstrated performance excellence in multi-disciplinary leadership roles including operations, marketing, sales, strategic planning, acquisitions and integrations on domestic and international level. Excel at turning around underperforming businesses with a combination of strong business acumen, outstanding leadership, customer relationships, and superior commercial execution. Dynamic leader with ability to build high performing teams and cross functional collaboration, align and inspire organizations towards a clear vision, and execute for sustainable results.

Experienced Board Member and leader with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Biotechnology, Team Leadership, Management, and Risk Financing. Strong business development professional with a MBA focused in Accounting from University of Wisconsin-Madison.

Tom Ross is a President at Grand River Aseptic Manufacturing and is based in Grand Rapids, Michigan. He has worked as Managing Director at DWH. Thomas studied at Michigan State University.

Patricio Massera was appointed Chief Executive Officer of AGC Biologics (formerly CMC Biologics) in May 2019. Patricio joined the company in 2012, as General Manager of Copenhagen-based CMC Biologics A/S. He later served as Chief Operating Officer in the Seattle-based company headquarters. As CEO, Patricio quickly developed a comprehensive people management strategy, recognizing that with a healthy company culture and highly engaged employees, AGC is best positioned to provide the highest-quality services to our customers. Across his 20 years of biologics experience, Patricio held several key executive positions at MSD AH, Intervet/Schering-Plough, Biogenesis-Bagó and other biotech companies in Spain, Brazil, and Argentina. With a background in biochemistry and business, Patricio has acted as a change agent in several integration processes and cultivated strong leadership teams, dedicated to developing, manufacturing, and controlling biotechnological products and vaccines for human and animal health. Patricio holds an MBA from UCEMA and a Biochemist degree from the University of Buenos Aires.